logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
Cardiovascular Drugs and Therapy 封面图

Cardiovascular Drugs and Therapy

IF3.1
论文数3147
被引数3639
期刊论文 3147
发表时间
delete
Interpreting Short-Term Safety and Albuminuria in the FINE-TURK RegistryFINE-TURK登记研究中短期安全性与白蛋白尿的解读
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-10-23
delete0
PREAI
deleteJingjing Shang; Li Li; Lianghui Tan
delete分享
delete收藏
Epicardial Versus Circulating Adiponectin: An Unresolved Distinction in Liraglutide‘s Anti-Arrhythmic Mechanism心外膜与循环脂联素：利拉鲁肽抗心律失常机制中一个未解决的区分
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-10-17
delete0
PREAI
deleteMiao Miao; Chen Zhikui
delete分享
delete收藏
miR‑18a‑5p Serves as a Diagnostic and Prognostic Biomarker and Attenuates Hypoxia‑Induced Cardiac Microvascular Endothelial Injury by Targeting the HIF1A/NF‑κB Pathway in Chronic Heart FailuremiR‑18a‑5p作为诊断和预后生物标志物，并通过靶向HIF1A/NF‑κB通路减轻缺氧诱导的心脏微血管内皮损伤，在慢性心力衰竭中的作用
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-10-15
delete0
PREAI
deleteMin-na Hou; Ying Sun; Rongwen Lin; Liqiu Yan; Jingwei Zheng
delete分享
delete收藏
Rethinking Plaque Stabilization with Evolocumab in Diabetes: Methodological Considerations from the YELLOW III Trial重新思考糖尿病中Evolocumab对斑块稳定化的作用：YELLOW III试验的方法学考量
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-10-14
delete0
PREAI
deleteJianqi Qiao; Taotao Li
delete分享
delete收藏
MSCs-derived Exosomal miRNA-335-5p Alleviates Apoptosis and Inflammation in Myocardial Infarction by Inhibiting BCL2L11间充质干细胞来源的细胞外囊泡miRNA-335-5p通过抑制BCL2L11减轻心肌梗死中的凋亡和炎症
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-10-14
delete0
PREAI
deleteChan Wang; Zhou Ji
delete分享
delete收藏
Gut Microbiota and Its Metabolites in the Prognosis of Coronary Heart Disease: A Systematic Review and Mechanistic Insights肠道微生物群及其代谢物在冠状动脉心脏病预后中的作用：一项系统综述和机制见解
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-10-09
delete0
PREAI
deleteWeiting Cheng; Guiyang Xia; Huan Xia; Xuefen Wu; Xiaohan Liu; Xiaohong Wei; Sheng Lin
delete分享
delete收藏
Epac1 Functions as a Central Cardioprotective cAMP Effector During Ischemic and β-adrenergic PreconditioningEpac1在缺血和β-肾上腺素预适应过程中作为中心性的心脏保护性cAMP效应器
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-10-09
delete0
deleteOAAI
deleteM. S. Eriksen; F. E. Ravn; A. Aspevik; J. T. Haugom; A. Wergeland; K. S. Nordhus; R. Kopperud; M. Bakke; S. O. Døskeland; A. K. Jonassen
delete分享
delete收藏
Omega-3 Fatty Acids in the Management of Cardiovascular Disease PreventionOmega-3脂肪酸在心血管疾病预防管理中的应用
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-10-08
delete0
deleteOAAI
deleteSimone Finocchiaro; Luigi Cutore; Costanza Bordonaro; Carmelo Cusmano; Diego Nastasi; Francesco Nasisi; Davide Capodanno
delete分享
delete收藏
Precision Use of Ivabradine in Contemporary HFrEF: From Heart Rate Reduction to Physiological Optimization伊伐布雷定在当代射血分数降低心力衰竭中的精准应用：从心率降低到生理优化
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-10-07
delete0
PREAI
deleteTeruhiko Imamura
delete分享
delete收藏
Baxdrostat in Resistant and Uncontrolled Hypertension: A Systematic Review and Meta-AnalysisBaxdrostat在耐药性及未控制高血压中的应用：一项系统综述和Meta分析
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-10-06
delete0
PREAI
deleteAdir Alper; Mathias Lerner; Adina Fagin; Aditya Karthikeyan; Adam Gershon; Robert Faillace
delete分享
delete收藏
Combined Prognostic Value of Triglyceride-Glucose Index and Bilirubin in Drug-Eluting Stent Restenosis: From Clinical Risk Stratification to Exploratory Vascular-Cell Findings三酰甘油-葡萄糖指数和胆红素在药物洗脱支架再狭窄中的联合预后价值：从临床风险分层到探索性血管细胞发现
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-10-02
delete0
PREAI
deleteYingle Wu; Xiaopeng Qu; Yanhui Han; Mengnan Fan; Xuming Yang; Pingshuan Dong; Ke Wang; Laijing Du
delete分享
delete收藏
METTL3 Confers Ischemia/Reperfusion-Caused Myocardial Injury by Triggering Ferroptosis via Regulating the lncRNA SNHG14/miR-195a-5p/ACSL4 AxisMettl3通过调控lncRNA SNHG14/miR-195a-5p/ACSL4轴触发铁死亡，介导缺血/再灌注所致心肌损伤
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-10-02
delete0
PREAI
deleteGuorong Lai; Jie Yang; Mailin Zhao; Liangxian Zhu; Dongsheng Le; Li Liu; Chao Zhang; Fan Yang; Jian Wen; Shikai Gui; Yanhui Hu; Yingping Liang
delete分享
delete收藏
Allopurinol for Marfan Aortopathy: Pharmacogenomic Safety and Sex-Stratified Trial Design Warrant Consideration别嘌醇治疗马凡综合征主动脉病变：药物基因组学安全性及性别分层试验设计值得考虑
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-10-02
delete0
PREAI
deleteTahir Ullah; Muhammad Tariq Shah
delete分享
delete收藏
PDK4-Associated Metabolic Reprogramming Contributes to Lactate Accumulation and Parthanatos-Related Changes in Septic CardiomyocytesPDK4相关代谢重编程导致乳酸积累和脓毒症心肌细胞中与Parthanatos相关变化
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-09-29
delete0
PREAI
deleteShaodong Yang; Cairong Yan; Zhenwei Xu; Tianbao Huang; Jintu Chen; Jingfa Zhu
delete分享
delete收藏
Herpes Zoster Vaccination as Cardiovascular Prevention in Adults with Heart Disease带状疱疹疫苗接种作为心脏病患者心血管疾病预防措施
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-09-28
delete0
PREAI
deleteLorenzo Facila Rubio; Vicente Pallarés-Carratalá; Alberto Cordero; José Pérez Silvestre; Clara Bonanad Lozano
delete分享
delete收藏
Beyond KPAQ Improvement: Reassessing the Clinical Meaning of Cilostazol–Rosuvastatin Combination Therapy in Symptomatic Peripheral Artery Disease超越KPAQ改善：重新评估西洛他唑–瑞舒伐他汀联合疗法在症状性外周动脉疾病中的临床意义
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-09-26
delete0
PREAI
deleteJunao Chen
delete分享
delete收藏
Reply to Letter to the Editor: In-Hospital SGLT-2 Inhibitor Initiation in Acute Heart Failure回复给编辑的信：急性心力衰竭住院期间SGLT-2抑制剂启动
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-09-26
delete0
PREAI
deleteMuhammad Owais; Maham Altaf; Hafiz M. Ahmed
delete分享
delete收藏
Impact of Diabetes on Coronary Plaque Stabilization With Evolocumab: Insights From the YELLOW III Trial糖尿病对依洛尤单抗治疗下冠状动脉斑块稳定化的影响：YELLOW III试验的启示
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-09-24
delete0
PREAI
deleteKeisuke Yasumura; Yuliya Vengrenyuk; Jiajia Liu; Pruthvi C. Revaiah; Amit Hooda; Raman Sharma; Sahil Khera; Vishal Kapur; Joseph Sweeny; Prakash Krishnan; Pedro Moreno; Xiaobo Zhou; Jagat Narula; Roxana Mehran; Samin Sharma; Annapoorna S. Kini
delete分享
delete收藏
Introducing Allopurinol to the Medical Treatment of Marfan Syndrome: Advantages, Limitations, and Potential Extension to other Aortopathies将别嘌醇引入马凡综合征的医学治疗：优势、局限性与潜在扩展至其他主动脉病变
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-09-17
delete0
deleteOAAI
deleteGustavo Egea; Rodrigo Barbosa de Souza; Gisela Teixidó-Turà; Aleksandra Mas-Stachurska; Arturo Evangelista; Bart Loeys
delete分享
delete收藏
Energetic Decoding of VSMC Plasticity: Metabolic Reprogramming and Phenotypic Switching血管平滑肌细胞塑性的能量解码：代谢重编程和表型转换
deleteCardiovascular Drugs and Therapy
IF3.1
delete2026-09-17
delete0
PREAI
deleteTingyu Yan; Qian Nie; Bo Xu; Xin Peng; Jiecan Zhou
delete分享
delete收藏